ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #3,395Top JournalHybrid

Frontiers in Pharmacology

Abbreviation (ISO):Front. Pharmacol
•
Identifier (ISSN):1663-9812(Print)
•
Publisher:Frontiers Media S.A.
Clarivate IF (2026)
5.4↑ +0.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Frontiers in Pharmacology

WoS Q1
24683.8320183.8520194.2220205.8120215.9920225.620234.420244.820255.42026
Annual Impact Factor Metric
Current (2026):5.4
Scopus SJR & RankScopus Q1
1.248
#3,395

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
203

203 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate4.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
3,824articles/year
99.91% Gold OA•71.47% Original Research

Aims & Scope

Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.

Topics Covered (Recognized by AI)
Biology97.4%Medicine97.2%Internal medicine84.8%Chemistry80.4%Biochemistry74.6%Genetics74.5%Pharmacology54%Pathology46.4%Endocrinology44.1%Psychology36.1%Organic chemistry33%Immunology32.9%Gene30.6%Cell biology28%Physics27.2%Psychiatry27.1%Receptor22%Surgery21.2%Bioinformatics20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank60/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank69/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.4
Articles / Year3,171
Total Citations1,588
2025
IF4.8
Articles / Year4,127
Total Citations18,500
2024
IF4.4
Articles / Year3,417
Total Citations34,491
2023
IF5.6
Articles / Year3,347
Total Citations51,050
2022
IF5.988
Articles / Year5,823
Total Citations123,507

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,395Scopus Q1SCImago Profile
Scopus Coverage:2010-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.248

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.07

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,415 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations70,415
3-Year Documents12,584
Citable Documents11,879

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate46.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ1
Pharmacology (medical)Q1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Frontiers in Pharmacology (abbr: Front. Pharmacol, ISSN: 1663-9812) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Frontiers Media S.A. in Switzerland. The periodical holds a Journal Impact Factor (JIF) of 5.40, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.248 (Q1), an H-index of 203.

The journal enforces rigorous peer evaluation with an annual output of approximately 3,824 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,415 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Frontiers Media S.A.
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 10b2f52c-2f2a-4b93-b51c-2f74cdcd220d
Database Updated: 2026-09-29